封面
市場調查報告書
商品編碼
1544668

子宮腔鏡器材市場、機會、成長動力、產業趨勢分析與預測,2024-2032

Hysteroscopy Instruments Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於婦科疾病盛行率不斷上升以及對微創手術的需求不斷成長,子宮腔鏡器械市場規模預計在 2024 年至 2032 年期間複合年成長率為 7.4%。報告顯示,全球92%的女性患有一種或多種婦科疾病。子宮腔鏡檢查有助於以最少的手術干預對子宮腔進行詳細檢查和治療。異常出血、息肉和肌瘤等疾病的發生率不斷上升,再加上門診和微創手術的轉變,刺激了對先進子宮鏡儀器的需求。

此外,隨著醫療設施的現代化和先進婦科護理的普及,對複雜子宮鏡儀器的需求不斷增加。技術先進的工具(例如具有高清成像和整合功能的數位子宮腔鏡)的出現,吸引了旨在提高臨床結果和手術效率的醫療保健提供者,從而促進了市場成長。

整個產業分為類型、可用​​性、應用程式、最終用戶和地區。

根據類型,電切鏡領域的子宮腔鏡器械市場價值預計到 2032 年將產生可觀的收入,因為它們在診斷和治療婦科手術中發揮關鍵作用。電切鏡使外科醫師能夠從子宮腔精確切除異常組織,如息肉和肌瘤,從而增強微創治療的有效性。

子宮腔鏡診斷應用領域的子宮腔鏡器械市場規模預計將在 2024 年至 2032 年期間出現強勁的複合年成長率。診斷性子宮腔鏡檢查能夠直接觀察子宮腔,確保準確辨識息肉、子宮肌瘤和子宮內膜異常等病症。婦科對早期診斷和預防性護理的日益重視推動了對能夠實現精確成像和徹底檢查的先進診斷工具的需求。

亞太地區子宮腔鏡器械產業規模將在 2024 年至 2032 年間成長。此外,龐大且多樣化的人口、不斷增加的醫療保健支出以及政府努力提高獲得優質醫療服務的機會,將進一步增加該地區對子宮鏡檢查工具的需求。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 越來越多採用微創治療
      • 擴大採用辦公室子宮鏡檢查
      • 婦科疾病發生率上升
    • 產業陷阱與挑戰
      • 與子宮腔鏡手術相關的副作用
      • 婦科疾病診斷和治療的替代方案的可用性
  • 2021 年至 2032 年子宮腔鏡手術總數
  • 成長潛力分析
  • 報銷場景
  • 未來市場趨勢
  • 監管環境
  • 技術景觀
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按類型,2021 - 2032

  • 主要趨勢
  • 子宮腔鏡
    • 硬質子宮腔鏡
    • 軟性子宮腔鏡
  • 電切鏡
    • 雙極電切鏡
    • 單極電切鏡
  • 流體管理系統
  • 手持式儀器
    • 鉗子
    • 剪刀
    • 擴張器
    • 其他手持式儀器
  • 子宮套
  • 子宮腔鏡組織切除系統

第 6 章:市場估計與預測:按可用性分類,2021 - 2032 年

  • 主要趨勢
  • 可重複使用的儀器
  • 免洗器械

第 7 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 診斷性子宮腔鏡檢查
  • 子宮腔鏡手術
    • 子宮肌瘤切除術
    • 息肉切除術
    • 子宮內膜去除術
    • 輸卵管絕育術

第 8 章:市場估計與預測:按最終用戶分類,2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第 9 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CooperSurgical, Inc.
  • EMOS Technology GmbH
  • Endoservice GmbH
  • Erbe Elektromedizin GmbH
  • Hologic, Inc.
  • Johnson and Johnson Services, Inc.
  • KARL STORZ SE and Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith and Nephew plc
  • Stryker Corporation
  • XION GmbH
簡介目錄
Product Code: 10203

Hysteroscopy instruments market size is set to record a 7.4% CAGR during 2024-2032 driven by the increasing prevalence of gynecological conditions and the rising demand for minimally invasive procedures. Reports indicate that 92% of women globally suffer from one or more gynecological diseases. Hysteroscopy facilitates a detailed examination and treatment of the uterine cavity with minimal surgical intervention. The rising incidence of conditions like abnormal bleeding, polyps, and fibroids, coupled with a shift towards outpatient and minimally invasive procedures, fuels the demand for advanced hysteroscopy instruments.

Furthermore, as medical facilities modernize and access to advanced gynecological care expands, the demand for sophisticated hysteroscopy instruments intensifies. The emergence of technologically advanced tools, such as digital hysteroscopes boasting high-definition imaging and integration capabilities, draws healthcare providers aiming to enhance clinical outcomes and procedural efficiency, adding to the market growth.

The overall industry is divided into type, usability, application, end user, and region.

Based on type, the hysteroscopy instruments market value from the resectoscopes segment is expected to generate notable revenue by 2032 due to their critical role in both diagnostic and therapeutic gynecological procedures. Resectoscopes empower surgeons to precisely resect and remove abnormal tissues, like polyps and fibroids, from the uterine cavity, bolstering the effectiveness of minimally invasive treatments.

Hysteroscopy instruments market size from the diagnostics hysteroscopy application segment is projected to observe a robust CAGR during 2024 - 2032. This is owing to its essential role in the early detection and diagnosis of uterine abnormalities. With the ability to directly visualize the uterine cavity, diagnostic hysteroscopy ensures accurate identification of conditions, such as polyps, fibroids, and endometrial abnormalities. The growing emphasis on early diagnosis and preventative care in gynecology propels the demand for advanced diagnostic tools that promise precise imaging and thorough examination.

Asia Pacific hysteroscopy instruments industry size will grow between 2024 and 2032. The rapid technological advancements in medicine, combined with an emphasis on minimally invasive procedures, are driving the adoption of advanced hysteroscopy instruments. Furthermore, the vast and varied population, increasing healthcare spending, and government efforts to enhance access to superior medical care will further bolster the regional demand for hysteroscopy tools.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing adoption of minimally invasive treatments
      • 3.2.1.2 Increasing adoption of office hysteroscopy
      • 3.2.1.3 Rising incidence of gynecological diseases
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Side effects associated with hysteroscopy procedures
      • 3.2.2.2 Availability of alternative options for diagnosis and treatment of gynecological conditions
  • 3.3 Total number of hysteroscopy procedures, 2021 - 2032
  • 3.4 Growth potential analysis
  • 3.5 Reimbursement scenario
  • 3.6 Future market trends
  • 3.7 Regulatory landscape
  • 3.8 Technological landscape
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hysteroscopes
    • 5.2.1 Rigid hysteroscopes
    • 5.2.2 Flexible hysteroscopes
  • 5.3 Resectoscopes
    • 5.3.1 Bipolar resectoscopes
    • 5.3.2 Unipolar resectoscopes
  • 5.4 Fluid management systems
  • 5.5 Handheld instruments
    • 5.5.1 Forceps
    • 5.5.2 Scissors
    • 5.5.3 Dilators
    • 5.5.4 Other handheld instruments
  • 5.6 Hysterosheaths
  • 5.7 Hysteroscopic tissue removal systems

Chapter 6 Market Estimates and Forecast, By Usability, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Reusable instruments
  • 6.3 Disposable instruments

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Diagnostic hysteroscopy
  • 7.3 Operative hysteroscopy
    • 7.3.1 Myomectomy
    • 7.3.2 Polypectomy
    • 7.3.3 Endometrial ablation
    • 7.3.4 Tubal sterilization

Chapter 8 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgery centers
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 B. Braun Melsungen AG
  • 10.2 Boston Scientific Corporation
  • 10.3 CooperSurgical, Inc.
  • 10.4 EMOS Technology GmbH
  • 10.5 Endoservice GmbH
  • 10.6 Erbe Elektromedizin GmbH
  • 10.7 Hologic, Inc.
  • 10.8 Johnson and Johnson Services, Inc.
  • 10.9 KARL STORZ SE and Co. KG
  • 10.10 Medtronic plc
  • 10.11 Olympus Corporation
  • 10.12 Richard Wolf GmbH
  • 10.13 Smith and Nephew plc
  • 10.14 Stryker Corporation
  • 10.15 XION GmbH